Lv43
460 积分 2023-05-02 加入
A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy
36分钟前
已完结
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer
1天前
已完结
Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study
1天前
已完结
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
1天前
已完结
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
7个月前
已完结
European Lung Cancer Congress 2024
1年前
已关闭
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
1年前
已完结
European Lung Cancer Congress 2024
1年前
已关闭
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
1年前
已完结
Hallmarks of Cancer: New Dimensions
1年前
已完结
皖公网安备34019202002308
